2023 Q4 Form 10-Q Financial Statement
#000186074223000029 Filed on November 01, 2023
Income Statement
| Concept | 2023 Q4 | 2023 Q3 |
|---|---|---|
| Revenue | $1.173B | $1.007B |
| YoY Change | 17.77% | 6.9% |
| Cost Of Revenue | $461.0M | $392.0M |
| YoY Change | 9.76% | 5.38% |
| Gross Profit | $712.0M | $615.0M |
| YoY Change | 23.61% | 7.89% |
| Gross Profit Margin | 60.7% | 61.07% |
| Selling, General & Admin | $465.0M | $418.0M |
| YoY Change | 20.47% | 9.71% |
| % of Gross Profit | 65.31% | 67.97% |
| Research & Development | $79.00M | $82.00M |
| YoY Change | 1.28% | 6.49% |
| % of Gross Profit | 11.1% | 13.33% |
| Depreciation & Amortization | $80.00M | $82.00M |
| YoY Change | -13.98% | -11.83% |
| % of Gross Profit | 11.24% | 13.33% |
| Operating Expenses | $624.0M | $500.0M |
| YoY Change | 20.0% | 9.17% |
| Operating Profit | $88.00M | $40.00M |
| YoY Change | 57.14% | -13.04% |
| Interest Expense | -$106.0M | -$75.00M |
| YoY Change | 100.0% | 177.78% |
| % of Operating Profit | -120.45% | -187.5% |
| Other Income/Expense, Net | -$28.00M | |
| YoY Change | 300.0% | |
| Pretax Income | -$57.00M | -$35.00M |
| YoY Change | 2750.0% | -284.21% |
| Income Tax | -$6.000M | $45.00M |
| % Of Pretax Income | ||
| Net Earnings | -$54.00M | -$84.00M |
| YoY Change | 5300.0% | 366.67% |
| Net Earnings / Revenue | -4.6% | -8.34% |
| Basic Earnings Per Share | -$0.24 | |
| Diluted Earnings Per Share | -$0.15 | -$0.24 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 350.9M shares | 350.7M shares |
| Diluted Shares Outstanding | 350.8M shares |
Balance Sheet
| Concept | 2023 Q4 | 2023 Q3 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $331.0M | $355.0M |
| YoY Change | -6.5% | 23.69% |
| Cash & Equivalents | $331.0M | $355.0M |
| Short-Term Investments | ||
| Other Short-Term Assets | $544.0M | $572.0M |
| YoY Change | 26.22% | 102.84% |
| Inventory | $1.028B | $754.0M |
| Prepaid Expenses | ||
| Receivables | $839.0M | $783.0M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $2.742B | $2.464B |
| YoY Change | 28.31% | 32.54% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $1.390B | $1.284B |
| YoY Change | 6.92% | 5.07% |
| Goodwill | $4.575B | $4.526B |
| YoY Change | 1.51% | 2.51% |
| Intangibles | $3.589B | $3.662B |
| YoY Change | 74.39% | 77.08% |
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $225.0M | $212.0M |
| YoY Change | 4.65% | -7.02% |
| Total Long-Term Assets | $10.70B | $10.60B |
| YoY Change | 18.8% | 20.0% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $2.742B | $2.464B |
| Total Long-Term Assets | $10.70B | $10.60B |
| Total Assets | $13.44B | $13.07B |
| YoY Change | 20.62% | 22.18% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $522.0M | $364.0M |
| YoY Change | 41.08% | 23.39% |
| Accrued Expenses | $1.027B | $992.0M |
| YoY Change | 13.98% | 12.86% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $30.00M | $30.00M |
| YoY Change | 20.0% | 20.0% |
| Total Short-Term Liabilities | $1.579B | $1.386B |
| YoY Change | 21.84% | 15.6% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $4.532B | $4.435B |
| YoY Change | 87.97% | 83.8% |
| Other Long-Term Liabilities | $397.0M | $353.0M |
| YoY Change | 20.67% | 26.52% |
| Total Long-Term Liabilities | $4.929B | $4.788B |
| YoY Change | 79.89% | 77.86% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $1.579B | $1.386B |
| Total Long-Term Liabilities | $4.929B | $4.788B |
| Total Liabilities | $6.522B | $6.185B |
| YoY Change | 61.32% | 58.55% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$254.0M | -$200.0M |
| YoY Change | -4333.33% | -2957.14% |
| Common Stock | $8.349B | $8.334B |
| YoY Change | 0.77% | 2.79% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $6.850B | $6.817B |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $13.44B | $13.07B |
| YoY Change | 20.62% | 22.18% |
Cashflow Statement
| Concept | 2023 Q4 | 2023 Q3 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$54.00M | -$84.00M |
| YoY Change | 5300.0% | 366.67% |
| Depreciation, Depletion And Amortization | $80.00M | $82.00M |
| YoY Change | -13.98% | -11.83% |
| Cash From Operating Activities | $15.00M | $48.00M |
| YoY Change | -90.57% | 77.78% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $84.00M | $33.00M |
| YoY Change | 68.0% | -167.35% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$51.00M | -$1.849B |
| YoY Change | 27.5% | |
| Cash From Investing Activities | -$135.0M | -$1.882B |
| YoY Change | 50.0% | 3740.82% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 86.00M | 1.811B |
| YoY Change | -1328.57% | -1761.47% |
| NET CHANGE | ||
| Cash From Operating Activities | 15.00M | 48.00M |
| Cash From Investing Activities | -135.0M | -1.882B |
| Cash From Financing Activities | 86.00M | 1.811B |
| Net Change In Cash | -34.00M | -23.00M |
| YoY Change | -154.84% | -82.44% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $15.00M | $48.00M |
| Capital Expenditures | $84.00M | $33.00M |
| Free Cash Flow | -$69.00M | $15.00M |
| YoY Change | -163.3% | -80.26% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
|
2000000 | usd | |
| us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
|
4000000 | usd | |
| CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
7030000000 | usd |
| CY2023Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
16000000 | usd |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.02 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.02 | ||
| CY2023Q3 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
|
1000000 | usd |
| CY2022Q3 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
|
1000000 | usd |
| CY2023Q3 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
3000000 | usd |
| CY2023Q3 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
9000000 | usd |
| CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-80000000 | usd |
| CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-71000000 | usd |
| CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
6883000000 | usd |
| CY2022Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
6971000000 | usd |
| CY2022Q3 | blco |
Adjustments To Additional Paid In Capital Distributions To Affiliates
AdjustmentsToAdditionalPaidInCapitalDistributionsToAffiliates
|
2000000 | usd |
| CY2022Q3 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
11000000 | usd |
| CY2022Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
18000000 | usd |
| CY2022Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-15000000 | usd |
| CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-170000000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
7101000000 | usd |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
58000000 | usd | |
| us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
9000000 | usd | |
| us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
9000000 | usd | |
| us-gaap |
Profit Loss
ProfitLoss
|
-197000000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-61000000 | usd | |
| CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
6883000000 | usd |
| CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
9402000000 | usd |
| us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
0 | usd | |
| blco |
Net Parent Investment Decrease In Conjunction With Legal Reorganization
NetParentInvestmentDecreaseInConjunctionWithLegalReorganization
|
2200000000 | usd | |
| blco |
Adjustments To Additional Paid In Capital Distributions To Affiliates
AdjustmentsToAdditionalPaidInCapitalDistributionsToAffiliates
|
-85000000 | usd | |
| us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
11000000 | usd | |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
29000000 | usd | |
| us-gaap |
Profit Loss
ProfitLoss
|
15000000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-355000000 | usd | |
| CY2022Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
6795000000 | usd |
| us-gaap |
Profit Loss
ProfitLoss
|
-197000000 | usd | |
| us-gaap |
Profit Loss
ProfitLoss
|
15000000 | usd | |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
266000000 | usd | |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
286000000 | usd | |
| us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
25000000 | usd | |
| us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
5000000 | usd | |
| us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd | |
| us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
1000000 | usd | |
| blco |
Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
|
13000000 | usd | |
| blco |
Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
|
20000000 | usd | |
| blco |
Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
|
-9000000 | usd | |
| blco |
Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
|
-39000000 | usd | |
| us-gaap |
Proceeds From Legal Settlements
ProceedsFromLegalSettlements
|
2000000 | usd | |
| us-gaap |
Payments For Legal Settlements
PaymentsForLegalSettlements
|
4000000 | usd | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
58000000 | usd | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
45000000 | usd | |
| us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-11000000 | usd | |
| us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
10000000 | usd | |
| blco |
Derivative Gain Excluded Component
DerivativeGainExcludedComponent
|
10000000 | usd | |
| blco |
Derivative Gain Excluded Component
DerivativeGainExcludedComponent
|
3000000 | usd | |
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
4000000 | usd | |
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
23000000 | usd | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
82000000 | usd | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
68000000 | usd | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
144000000 | usd | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
108000000 | usd | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
18000000 | usd | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
10000000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
57000000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
79000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-32000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
186000000 | usd | |
| us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
1892000000 | usd | |
| us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
5000000 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
97000000 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
125000000 | usd | |
| us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
13000000 | usd | |
| us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
15000000 | usd | |
| us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
14000000 | usd | |
| us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
20000000 | usd | |
| us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
1000000 | usd | |
| us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
0 | usd | |
| us-gaap |
Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
|
13000000 | usd | |
| us-gaap |
Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
|
0 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1974000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-125000000 | usd | |
| us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
2180000000 | usd | |
| us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
2440000000 | usd | |
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
154000000 | usd | |
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
6000000 | usd | |
| us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
9000000 | usd | |
| us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
0 | usd | |
| us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
16000000 | usd | |
| us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
3000000 | usd | |
| us-gaap |
Payments To Minority Shareholders
PaymentsToMinorityShareholders
|
9000000 | usd | |
| us-gaap |
Payments To Minority Shareholders
PaymentsToMinorityShareholders
|
11000000 | usd | |
| blco |
Net Borrowings Financing Activities
NetBorrowingsFinancingActivities
|
0 | usd | |
| blco |
Net Borrowings Financing Activities
NetBorrowingsFinancingActivities
|
31000000 | usd | |
| blco |
Net Transfers Financing Activities
NetTransfersFinancingActivities
|
0 | usd | |
| blco |
Net Transfers Financing Activities
NetTransfersFinancingActivities
|
2363000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1992000000 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
88000000 | usd | |
| us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-6000000 | usd | |
| us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-29000000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-20000000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
120000000 | usd | |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
380000000 | usd |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
177000000 | usd |
| CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
360000000 | usd |
| CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
297000000 | usd |
| us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
34000000 | usd | |
| us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
18000000 | usd | |
| us-gaap |
Notes Issued1
NotesIssued1
|
0 | usd | |
| us-gaap |
Notes Issued1
NotesIssued1
|
2200000000 | usd | |
| us-gaap |
Nature Of Operations
NatureOfOperations
|
DESCRIPTION OF BUSINESS<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. The Company operates in three reportable segments: (i) Vision Care segment which includes both a contact lens business and a consumer eye care business that consists of contact lens care products, over-the-counter (“OTC”) eye drops and eye vitamins, (ii) Pharmaceuticals segment which consists of a broad line of proprietary and generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases and (iii) Surgical segment which consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes intraocular lenses (“IOLs”) and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for ophthalmic surgery. Effective June 30, 2023, the Company renamed its former Ophthalmic Pharmaceuticals segment to the Pharmaceuticals segment. Aside from the change in name, there were no other changes made to this segment at that time. See Note 18, “SEGMENT INFORMATION” for additional information regarding these reportable segments. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bausch + Lomb is a subsidiary of Bausch Health Companies Inc. (“BHC”), with BHC holding, directly or indirectly, approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88.5%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the issued and outstanding common shares of Bausch + Lomb as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 27, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Separation of Bausch + Lomb</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2020, BHC announced its plan to separate Bausch + Lomb into an independent, publicly traded company, separate from the remainder of BHC (the “Separation”), commencing with an initial public offering of Bausch + Lomb's common shares (as further described below). Prior to January 1, 2022, Bausch + Lomb had nominal assets and liabilities. In connection with the B+L IPO (as defined below), BHC transferred to Bausch + Lomb, in a series of steps, all the entities, assets, liabilities and obligations that Bausch + Lomb held upon completion of the B+L IPO pursuant to a Master Separation Agreement (the “MSA”) with BHC. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement related to the initial public offering (the “IPO”) of Bausch + Lomb’s common shares (the “B+L IPO”) was declared effective on May 5, 2022, and Bausch + Lomb’s common shares began trading on the New York Stock Exchange and the Toronto Stock Exchange, in each case under the ticker symbol “BLCO”, on May 6, 2022. Bausch + Lomb also obtained a final receipt to its Canadian base PREP prospectus on May 5, 2022. Prior to the B+L IPO, Bausch + Lomb was a wholly-owned subsidiary of BHC. On May 10, 2022, a wholly-owned subsidiary of BHC (the “Selling Shareholder”) sold 35,000,000 common shares of Bausch + Lomb, at an offering price of $18.00 per share (less the applicable underwriting discount), pursuant to the Bausch + Lomb prospectuses. In addition, the Selling Shareholder granted the underwriters an option for a period of 30 days from the date of the B+L IPO to purchase up to an additional 5,250,000 common shares to cover over-allotments at the IPO price less underwriting commissions. On May 31, 2022, the underwriters for the B+L IPO partially exercised the over-allotment option granted by the Selling Shareholder and, on June 1, 2022, the Selling Shareholder sold an additional 4,550,357 common shares of Bausch + Lomb at an offering price of $18.00 per share (less the applicable underwriting discount). The remainder of the over-allotment option granted to the underwriters expired. The Selling Shareholder received all net proceeds from the B+L IPO and the partial exercise of the over-allotment option by the underwriters. As of October 27, 2023, BHC directly or indirectly held 310,449,643 common shares of Bausch + Lomb, which represented approximately 88.5% of the issued and outstanding common shares of Bausch + Lomb. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The completion of the full Separation of Bausch + Lomb, which includes the transfer of all or a portion of BHC’s remaining direct or indirect equity interest in Bausch + Lomb to its shareholders (the “Distribution”), is subject to the achievement of targeted debt leverage ratios and the receipt of applicable shareholder and other necessary approvals and other factors and is subject to various risk factors relating to the Separation. Bausch + Lomb understands that BHC continues to believe that completing the B+L Separation makes strategic sense and that BHC continues to evaluate all relevant factors and considerations related to completing the Separation, including the effect of the lawsuit filed against Norwich Pharmaceuticals Inc.</span></div> | ||
| us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
3 | segment | |
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
3 | segment | |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the Company’s Condensed Consolidated Financial Statements, management is required to make estimates and assumptions. This includes estimates and assumptions regarding the nature, timing and extent of the impacts that certain global macroeconomic conditions, including, but not limited to, those related to inflation and supply chain, will have on the Company's operations and cash flows. The estimates and assumptions used by the Company affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include: provisions for product returns, rebates, chargebacks, discounts and allowances and distribution fees paid to certain wholesalers; useful lives of finite-lived intangible assets and property, plant and equipment; expected future cash flows used in evaluating intangible assets for impairment, assessing compliance with debt covenants, reporting unit fair values for testing goodwill for impairment; acquisition-related contingent consideration liabilities; provisions for loss contingencies; provisions for income taxes, uncertain tax positions and realizability of deferred tax assets; the fair value of cross-currency swaps; and the fair value of foreign currency exchange contracts. Prior to the B+L IPO, significant estimates made by management also included the related allocations described in the basis of presentation.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All estimates in these Condensed Consolidated Financial Statements are based on assumptions that management believes are reasonable. On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company's business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company's business, financial condition, cash flows and results of operations could be materially impacted.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which certain global macroeconomic conditions, including, but not limited to, those related to inflation and supply chain, may continue to impact the Company’s business, financial condition, cash flows and results of operations, in particular, will depend on future developments which are highly uncertain and many of which are outside the Company’s control. The Company has assessed the possible effects and outcomes of these macroeconomic conditions on, among other things, its supply chain, customers and distributors, discounts and rebates, employee base, product sustainability, research and development efforts, product pipeline and consumer demand and currently believes that its estimates are reasonable.</span></div> | ||
| CY2022Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
484000000 | usd |
| us-gaap |
Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
|
1165000000 | usd | |
| us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
1180000000 | usd | |
| CY2023Q3 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
469000000 | usd |
| CY2021Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
468000000 | usd |
| us-gaap |
Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
|
1047000000 | usd | |
| us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
1001000000 | usd | |
| CY2022Q3 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
514000000 | usd |
| CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
22000000 | usd |
| CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
16000000 | usd |
| us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
3000000 | usd | |
| us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
2000000 | usd | |
| us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
2000000 | usd | |
| us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
2000000 | usd | |
| blco |
Accounts Receivable Allowance For Foreign Exchange And Other
AccountsReceivableAllowanceForForeignExchangeAndOther
|
-1000000 | usd | |
| blco |
Accounts Receivable Allowance For Foreign Exchange And Other
AccountsReceivableAllowanceForForeignExchangeAndOther
|
2000000 | usd | |
| CY2023Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
22000000 | usd |
| CY2022Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
18000000 | usd |
| CY2022Q4 | blco |
Related Party Net Borrowings
RelatedPartyNetBorrowings
|
0 | usd |
| CY2023Q3 | blco |
Related Party Cash Pooling And General Financing Activities
RelatedPartyCashPoolingAndGeneralFinancingActivities
|
0 | usd |
| CY2022Q3 | blco |
Related Party Cash Pooling And General Financing Activities
RelatedPartyCashPoolingAndGeneralFinancingActivities
|
2000000 | usd |
| blco |
Related Party Cash Pooling And General Financing Activities
RelatedPartyCashPoolingAndGeneralFinancingActivities
|
0 | usd | |
| blco |
Related Party Cash Pooling And General Financing Activities
RelatedPartyCashPoolingAndGeneralFinancingActivities
|
-227000000 | usd | |
| CY2023Q3 | blco |
Related Party Corporate Allocations
RelatedPartyCorporateAllocations
|
0 | usd |
| CY2022Q3 | blco |
Related Party Corporate Allocations
RelatedPartyCorporateAllocations
|
0 | usd |
| blco |
Related Party Corporate Allocations
RelatedPartyCorporateAllocations
|
0 | usd | |
| blco |
Related Party Corporate Allocations
RelatedPartyCorporateAllocations
|
76000000 | usd | |
| CY2023Q3 | blco |
Related Party Benefit From Income Taxes
RelatedPartyBenefitFromIncomeTaxes
|
0 | usd |
| CY2022Q3 | blco |
Related Party Benefit From Income Taxes
RelatedPartyBenefitFromIncomeTaxes
|
0 | usd |
| blco |
Related Party Benefit From Income Taxes
RelatedPartyBenefitFromIncomeTaxes
|
0 | usd | |
| blco |
Related Party Benefit From Income Taxes
RelatedPartyBenefitFromIncomeTaxes
|
66000000 | usd | |
| CY2023Q3 | blco |
Related Party Total Net Transfers
RelatedPartyTotalNetTransfers
|
0 | usd |
| CY2022Q3 | blco |
Related Party Total Net Transfers
RelatedPartyTotalNetTransfers
|
2000000 | usd |
| blco |
Related Party Total Net Transfers
RelatedPartyTotalNetTransfers
|
0 | usd | |
| blco |
Related Party Total Net Transfers
RelatedPartyTotalNetTransfers
|
-85000000 | usd | |
| blco |
Related Party Payment Of Purchase Debt
RelatedPartyPaymentOfPurchaseDebt
|
0 | usd | |
| blco |
Related Party Payment Of Purchase Debt
RelatedPartyPaymentOfPurchaseDebt
|
2200000000 | usd | |
| blco |
Related Party Net Transfers Allocated Share Based Payment Arrangement Noncash Expense
RelatedPartyNetTransfersAllocatedShareBasedPaymentArrangementNoncashExpense
|
0 | usd | |
| blco |
Related Party Net Transfers Allocated Share Based Payment Arrangement Noncash Expense
RelatedPartyNetTransfersAllocatedShareBasedPaymentArrangementNoncashExpense
|
16000000 | usd | |
| blco |
Related Party Net Transfers Other
RelatedPartyNetTransfersOther
|
0 | usd | |
| blco |
Related Party Net Transfers Other
RelatedPartyNetTransfersOther
|
62000000 | usd | |
| blco |
Net Transfers Financing Activities
NetTransfersFinancingActivities
|
0 | usd | |
| blco |
Net Transfers Financing Activities
NetTransfersFinancingActivities
|
2363000000 | usd | |
| CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
3360000000 | usd |
| CY2022Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
2058000000 | usd |
| CY2023Q3 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
200000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
163000000 | usd |
| CY2023Q3 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
66000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
44000000 | usd |
| CY2023Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
488000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
421000000 | usd |
| CY2023Q3 | us-gaap |
Inventory Gross
InventoryGross
|
754000000 | usd |
| CY2022Q4 | us-gaap |
Inventory Gross
InventoryGross
|
628000000 | usd |
| CY2022Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
4000000 | usd |
| CY2021Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
9000000 | usd |
| blco |
Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag
|
Acquisition-related contingent consideration adjustments | ||
| blco |
Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag
|
Acquisition-related contingent consideration adjustments | ||
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
0 | usd | |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
-5000000 | usd | |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
|
38000000 | usd | |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
|
0 | usd | |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
0 | usd | |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
0 | usd | |
| CY2023Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
42000000 | usd |
| CY2022Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
4000000 | usd |
| CY2023Q3 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
4000000 | usd |
| CY2022Q3 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
4000000 | usd |
| CY2023Q3 | us-gaap |
Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
38000000 | usd |
| CY2022Q3 | us-gaap |
Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
0 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
5457000000 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
3498000000 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1959000000 | usd |
| CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
3720000000 | usd |
| CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
3360000000 | usd |
| CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
360000000 | usd |
| CY2023Q3 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
7160000000 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
3498000000 | usd |
| CY2023Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3662000000 | usd |
| CY2022Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
5418000000 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
80000000 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
287000000 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
242000000 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
209000000 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
206000000 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
206000000 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
729000000 | usd |
| CY2023Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1959000000 | usd |
| CY2021Q4 | us-gaap |
Goodwill
Goodwill
|
4586000000 | usd |
| CY2022 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
5000000 | usd |
| CY2022 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
84000000 | usd |
| CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
4507000000 | usd |
| us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
31000000 | usd | |
| us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
12000000 | usd | |
| CY2023Q3 | us-gaap |
Goodwill
Goodwill
|
4526000000 | usd |
| CY2023 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
| CY2023Q3 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
198000000 | usd |
| CY2022Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
196000000 | usd |
| CY2023Q3 | blco |
Accrued Product Rebates Current
AccruedProductRebatesCurrent
|
143000000 | usd |
| CY2022Q4 | blco |
Accrued Product Rebates Current
AccruedProductRebatesCurrent
|
153000000 | usd |
| CY2023Q3 | blco |
Accrued Discounts And Allowances Current
AccruedDiscountsAndAllowancesCurrent
|
85000000 | usd |
| CY2022Q4 | blco |
Accrued Discounts And Allowances Current
AccruedDiscountsAndAllowancesCurrent
|
85000000 | usd |
| CY2023Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
74000000 | usd |
| CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
66000000 | usd |
| CY2023Q3 | blco |
Accrued Product Returns Current
AccruedProductReturnsCurrent
|
66000000 | usd |
| CY2022Q4 | blco |
Accrued Product Returns Current
AccruedProductReturnsCurrent
|
59000000 | usd |
| CY2023Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
426000000 | usd |
| CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
342000000 | usd |
| CY2023Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
992000000 | usd |
| CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
901000000 | usd |
| CY2023Q3 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
4544000000 | usd |
| CY2023Q3 | us-gaap |
Long Term Debt
LongTermDebt
|
4465000000 | usd |
| CY2022Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
2488000000 | usd |
| CY2022Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
2436000000 | usd |
| CY2023Q3 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
30000000 | usd |
| CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
25000000 | usd |
| CY2023Q3 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
4435000000 | usd |
| CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
2411000000 | usd |
| CY2023Q3 | us-gaap |
Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
|
0.0866 | |
| CY2022Q4 | us-gaap |
Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
|
0.0784 | |
| CY2023Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
16000000 | usd |
| CY2022Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
18000000 | usd |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
58000000 | usd | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
39000000 | usd | |
| CY2023Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
16000000 | usd |
| CY2022Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
18000000 | usd |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
58000000 | usd | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
39000000 | usd | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
3453000 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
6455000 | shares | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
18.21 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
18.00 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
5.33 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
4.55 | ||
| CY2023Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
101000000 | usd |
| us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y2M23D | ||
| CY2023Q3 | blco |
Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
|
77000000 | usd |
| CY2022Q3 | blco |
Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
|
71000000 | usd |
| blco |
Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
|
228000000 | usd | |
| blco |
Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
|
212000000 | usd | |
| CY2023Q3 | blco |
Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
|
5000000 | usd |
| CY2022Q3 | blco |
Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
|
6000000 | usd |
| blco |
Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
|
16000000 | usd | |
| blco |
Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
|
17000000 | usd | |
| CY2023Q3 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
82000000 | usd |
| CY2022Q3 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
77000000 | usd |
| us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
244000000 | usd | |
| us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
229000000 | usd | |
| CY2023Q3 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd |
| CY2022Q3 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
1000000 | usd |
| us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd | |
| us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
1000000 | usd | |
| CY2023Q3 | us-gaap |
Restructuring Charges
RestructuringCharges
|
11000000 | usd |
| CY2022Q3 | us-gaap |
Restructuring Charges
RestructuringCharges
|
5000000 | usd |
| us-gaap |
Restructuring Charges
RestructuringCharges
|
33000000 | usd | |
| us-gaap |
Restructuring Charges
RestructuringCharges
|
11000000 | usd | |
| CY2023Q3 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-2000000 | usd |
| CY2022Q3 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
0 | usd |
| us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-2000000 | usd | |
| us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
0 | usd | |
| CY2023Q3 | blco |
In Process Research And Development Expense
InProcessResearchAndDevelopmentExpense
|
0 | usd |
| CY2022Q3 | blco |
In Process Research And Development Expense
InProcessResearchAndDevelopmentExpense
|
1000000 | usd |
| blco |
In Process Research And Development Expense
InProcessResearchAndDevelopmentExpense
|
0 | usd | |
| blco |
In Process Research And Development Expense
InProcessResearchAndDevelopmentExpense
|
1000000 | usd | |
| CY2023Q3 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
16000000 | usd |
| CY2022Q3 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
0 | usd |
| us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
19000000 | usd | |
| us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
0 | usd | |
| CY2023Q3 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
-1000000 | usd |
| CY2022Q3 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
0 | usd |
| us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
0 | usd | |
| us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
-5000000 | usd | |
| CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-28000000 | usd |
| CY2022Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-7000000 | usd |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-54000000 | usd | |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-8000000 | usd | |
| us-gaap |
Severance Costs1
SeveranceCosts1
|
32000000 | usd | |
| us-gaap |
Severance Costs1
SeveranceCosts1
|
4000000 | usd | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
88000000 | usd | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
60000000 | usd | |
| CY2023Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
150000000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
54000000 | usd |
| CY2023Q3 | blco |
Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
|
70000000 | usd |
| CY2022Q4 | blco |
Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
|
70000000 | usd |
| CY2023Q3 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
10000000 | usd |
| CY2022Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
9000000 | usd |
| CY2023Q3 | us-gaap |
Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
|
63000000 | usd |
| CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
350000000 | shares |
| CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
350000000 | shares |
| CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-84000000 | usd |
| CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18000000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-206000000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
7000000 | usd | |
| CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
350800000 | shares |
| CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
350000000.0 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
350400000 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
350000000.0 | shares | |
| CY2023Q3 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares |
| CY2022Q3 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares |
| us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares | |
| us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
100000 | shares | |
| CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
350800000 | shares |
| CY2022Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
350000000.0 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
350400000 | shares | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
350100000 | shares | |
| CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.24 | |
| CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.24 | |
| CY2022Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.05 | |
| CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.05 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.59 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.59 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.02 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.02 | ||
| CY2023Q3 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
6000000 | usd |
| CY2023Q3 | blco |
Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
|
47000000 | usd |
| CY2022Q3 | blco |
Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
|
59000000 | usd |
| blco |
Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
|
160000000 | usd | |
| blco |
Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
|
188000000 | usd | |
| CY2023Q3 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-28000000 | usd |
| CY2022Q3 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-7000000 | usd |
| us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-54000000 | usd | |
| us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-8000000 | usd | |
| CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
40000000 | usd |
| CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
46000000 | usd |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
81000000 | usd | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
156000000 | usd | |
| CY2023Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
4000000 | usd |
| CY2022Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2000000 | usd |
| us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
12000000 | usd | |
| us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
3000000 | usd | |
| CY2023Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
76000000 | usd |
| CY2022Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
35000000 | usd |
| us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
184000000 | usd | |
| us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
99000000 | usd | |
| CY2023Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-3000000 | usd |
| CY2022Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
6000000 | usd |
| us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-18000000 | usd | |
| us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
15000000 | usd | |
| CY2023Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-35000000 | usd |
| CY2022Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
19000000 | usd |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-109000000 | usd | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
75000000 | usd | |
| CY2023Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1007000000 | usd |
| CY2022Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
942000000 | usd |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2973000000 | usd | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2772000000 | usd | |
| blco |
Concentration Risk Number Of Products Franchises
ConcentrationRiskNumberOfProductsFranchises
|
10 | product | |
| blco |
Concentration Risk Number Of Products Franchises
ConcentrationRiskNumberOfProductsFranchises
|
10 | product | |
| CY2023Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1007000000 | usd |
| CY2022Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
942000000 | usd |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2973000000 | usd | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2772000000 | usd |
